ADA and congenital bilateral aplasia of vas deferens from CFTR mutation: To underline the causality between aortic valve disease and differential expression of adenosine-metabolizing ecto-enzymes, we performed an interventional experiment using adenosine deaminase inhibitor in our mouse model of CAVD.